Vitamin D3-driven signals for myeloid cell differentiation—Implications for differentiation therapy
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Primitive myeloid leukemic cell lines can be driven to differentiate to monocyte-like cells by 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3), and, therefore, 1,25(OH)2D3 may be useful in differentiation therapy of myeloid leukemia and myelodysplastic syndromes (MDS). Recent studies have provided important insights into the mechanism of 1,25(OH)2D3-stimulated differentiation. For myeloid progenitors to complete monocytic differentiation a complex network of intracellular signals has to be activated and/or inactivated in a precise temporal and spatial pattern. 1,25(OH)2D3 achieves this change to the ‘signaling landscape’ by: i) direct genomic modulation of the level of expression of key regulators of cell signaling and differentiation pathways, and ii) activation of intracellular signaling pathways. An improved understanding of the mode of action of 1,25(OH)2D3 is facilitating the development of new therapeutic regimens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MAP kinase signalling pathways in cancer
Dhillon, A. S., Hagan, S., Rath, O., & Kolch, W. (2007) · Oncogene · doi:10.1038/sj.onc.1210421 · Cited by 2,995 · cited 3×
“MAPK signaling involves the creation of a multi-protein signaling complex (a signalosome) and cellular targets include transcription factors that drive differentiation [111,112].”
BackgroundAn Extensive Class of Small RNAs in Caenorhabditis elegans
Lee, R. C., & Ambros, V. (2001) · Science · doi:10.1126/science.1065329 · Cited by 2,922
Differential regulation and properties of MAPKs
Raman, M., Chen, W., & Cobb, M. H. (2007) · Oncogene · doi:10.1038/sj.onc.1210392 · Cited by 1,430
The specificities of protein kinase inhibitors: an update
BAIN, J., McLAUCHLAN, H., ELLIOTT, M., & COHEN, P. (2003) · Biochemical Journal · doi:10.1042/bj20021535 · Cited by 1,369 · cited 1×
“However, the specificity of many of the small molecule inhibitors used in the above studies has been questioned, especially when compounds are used at high concentrations [119-122].”
BackgroundRegulation of progenitor cell proliferation and granulocyte function by microRNA-223
Johnnidis, J. B., Harris, M. H., Wheeler, R. T., Stehling-Sun, S., Lam, M. H., Kirak, O., Brummelkamp, T. R., Fleming, M. D., & Camargo, F. D. (2008) · Nature · doi:10.1038/nature06607 · Cited by 1,208 · cited 1×
“Many studies have demonstrated the importance of individual microRNAs to diverse physiological processes, including hematopoietic cell development [158-161].”
BackgroundBioactive sphingolipids: metabolism and function
Bartke, N., & Hannun, Y. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800080-jlr200 · Cited by 683 · cited 1×
“Sphingolipid breakdown products (ceramide, sphingosine and sphingosine-1-phosphate) are a new class of lipids that regulate proliferation, apoptosis and differentiation [80].”
BackgroundSignalling through Class I PI3Ks in mammalian cells
Hawkins, P. T., Anderson, K. E., Davidson, K., & Stephens, L. R. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340647 · Cited by 540 · cited 1×
“Both p110α and p110β are found in most cells whilst p110δ and p110γ are usually only found in cells of hematopoietic origin [90].”
BackgroundThe proto-oncogene PU.1 regulates expression of the myeloid-specific CD11b promoter
Pahl, H. L., Scheibe, R. J., Zhang, D. E., Chen, H. M., Galson, D. L., Maki, R. A., & Tenen, D. G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53496-7 · Cited by 301
Chen, H. M., Pahl, H. L., Scheibe, R. J., Zhang, D. E., & Tenen, D. G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53086-6 · Cited by 199 · cited 1×
“1, Sp1 and perhaps c-jun have been reported to regulate expression from the CD11b promoter [100,101].”
BackgroundSignaling dynamics of the KSR1 scaffold complex
McKay, M. M., Ritt, D. A., & Morrison, D. K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901590106 · Cited by 163 · cited 2×
“Both KSR-1 and KSR-2 can associate with and phosphorylate Raf-1 in a stimulus-dependent manner in several model systems, and can act as scaffolds to facilitate the assembly at the cell membrane of Raf-1 protein and its downstream targets [129,130].”
Background
Cited by
Differentiation therapy revisited
de Thé, H. (2018) · Nature reviews. Cancer · doi:10.1038/nrc.2017.103 · Cited by 462
Callens, C., Coulon, S., Naudin, J., Radford-Weiss, I., Boissel, N., Raffoux, E., Wang, P. H. M., Agarwal, S., Tamouza, H., Paubelle, E., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091488 · Cited by 197
Vitamin D: Effect on Haematopoiesis and Immune System and Clinical Applications
Medrano, M., Carrillo-Cruz, E., Montero, I., & Perez-Simon, J. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092663 · Cited by 189
“1,25(OH)2D3 activates certain intracellular signalling pathways, which have been suggested to intersect at a common nodal point, Raf-1, such as: lipid signalling pathways (protein kinase C pathway), the phosphatidylinositol-3-kinase (PI3K)-AKT pathway and mitogen activated kinase (MAPK) pathways (Figure 2) [131,141].”
BackgroundInfluentialRetinoid X receptors in macrophage biology
Rőszer, T., Menéndez-Gutiérrez, M. P., Cedenilla, M., & Ricote, M. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.04.004 · Cited by 137
Metadata
- Authors
- Hughes, P. J., Marcinkowska, E., Gocek, E., Studzinski, G. P., & Brown, G.
- Venue
- Leukemia Research
- Publisher
- Elsevier BV
- Published
- 2010-05
- Volume
- 34
- Issue
- 5
- Pages
- 553-565
- ISSN
- 0145-2126 (ISSN-L)
- OpenAlex
- W2041240181
- Cited by
- 67
- References
- 12
- FWCI
- 3.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.